Citations

Mayo Clinic

Showing 10 of 108522 citations.

Echocardiographic Hemodynamics Correlate with Differences in DOAC-specific Bleeding and Stroke Rates in Non-Valvular Atrial Fibrillation
O’Shea, Michael P, Yusuf, Ali, Habib, Eiad , Ravi, Srekar , Chao, Chieh Ju, Newton, Sam , Scott, Robert L. , Barry, Timothy , Arsanjani, Reza, O’Shea, Michael , O’Shea, Michael P., Karikalan, Suganya Arunachalam , Chao, Chieh‐Ju , Ashraf, Hasan , Agasthi, Pradyumna , Arsanjani, Reza , Masry, Hicham El

No container title available | August 26, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4708572/v1 Get It

Abstract Aims : Direct oral anticoagulants (DOACs) are widely used for stroke prevention in people with non-valvular atrial fibrillation/flutter (NVAF). Anticoagulants have different bleeding profiles. Apixaban is associated with the lowest bleeding risk. This study evaluates the interaction between DOAC used and right ventricular systolic pressure (RVSP) on echocardiogram and bleeding rates. It was hypothesized that pulmonary hypertension may be associated with excess bleeding based on anticoagulant-specific pharmacologic profiles. Methods & Results : A retrospective analysis of a database was conducted. Multivariable regression models for bleeding rates were developed using a causative analysis approach among participants who had undergone an echocardiogram, and interaction terms for DOAC choice were incorporated. Stratum specific estimates were calculated using linear computation. Patients taking Apixaban had lower bleeding rates than those taking Rivaroxaban and Dabigatran. Among those without pulmonary hypertension, there was no difference in bleeding rates. Where RVSP was ≥45mmHg, there was a 90% increase in bleeding rates with use of Dabigatran (HR 1.99, p=0.024) and Rivaroxaban (HR 1.86, p=0.042) compared to Apixaban (Figure 1). Conclusions : Elevated RVSP is associated with excess bleeding in patients taking Rivaroxaban and Dabigatran, but not Apixaban, after controlling for confounding variables.
Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases
Moaven, Omeed , Mainali, Bigyan B. , Valenzuela, Cristian D. , Corvera, Carlos U. , Wisneski, Andrew D. , Shen, Perry , Shen, Perry , Moaven, Omeed , Russell, Gregory B. , Cheung, Tan To , Cha, Charles , Stauffer, John

Journal of Surgical Oncology | August 26, 2024 | Volume: 130 | Issue: 8 | Pages: 1654-1661

10.1002/jso.27846 | PMID 39183490 Get It

AbstractBackgroundThis study investigates the impact of margin status after colorectal liver metastasis (CLM) resection on outcomes of patients after neoadjuvant treatment versus those who underwent upfront resection.MethodsAn international collaborative database of CLM patients who underwent surgical resection was used. Proportional hazard regression models were created for single and multivariable models to assess the relationship between independent measures and median overall survival (mOS).ResultsR1 was associated with worse OS in the neoadjuvant group (mOS: 51.8 m for R0 vs. 26.0 m for R1; HR: 2.18). In the patients who underwent upfront surgery, R1 was not associated with OS. (mOS: 46.7 m for R0 vs. 42.6 m for R1). When patients with R1 in each group were stratified by adjuvant treatment, there was no significant difference in the neoadjuvant group, while in the upfront surgery group with R1, adjuvant treatment was associated with significant improvement in OS (mOS: 42.6 m for adjuvant vs. 25.0 m for no adjuvant treatment; HR: 0.21).ConclusionR1 is associated with worse outcomes in the patients who receive neoadjuvant treatment with no significant improvement with the addition of adjuvant therapy, likely representing an aggressive tumor biology. R1 did not impact OS in patients with upfront surgery who received postoperative chemotherapy.
The Absence of Items Addressing Increased Appetite or Weight in Depressive-Symptom Questionnaires: Implications for Understanding the Link between Major Depressive Disorder, Antidepressants, and Obesity
Treviño‐Alvarez, Andrés M. , Gluck, Marci E. , McElroy, Susan L., Cuéllar‐Barboza, Alfredo B. , Cuellar-Barboza, Alfredo , McElroy, Susan L.

Brain Sciences | August 26, 2024 | Volume: 14 | Issue: 8 | Pages: 841

10.3390/brainsci14080841 | PMID 39199532 Get It

Major depressive disorder (MDD) and obesity have a complex bidirectional relationship. However, most studies do not assess increased appetite or weight as a depressive symptom due to limitations in rating scales. Here we aimed to analyze frequently employed depressive-symptom scales and discuss the relevance of weight and appetite assessment items. To elaborate this perspective, we searched for validated questionnaires and scales evaluating depressive symptoms in English. We analyzed appetite and weight items from 20 depressive-symptoms rating scales. Only 8 of 20 rating scales assessed for increased weight or appetite. The scales reported in the literature as the most employed in antidepressants efficacy trials do not assess increased appetite or weight. The current use of rating scales limits our understanding of the relationship between MDD, antidepressants, and obesity. It is necessary to improve our weight and appetite measurements in MDD to clarify the respective impact of depressive symptoms and antidepressants on weight change.
Ablation Strategies for Persistent Atrial Fibrillation: Beyond the Pulmonary Veins
Baqal, Omar , Shafqat, Areez , Kulthamrongsri, Narathorn , Sanghavi, Neysa , Iyengar, Shruti Krishna , Vemulapalli, Hema Srikanth , Masry, Hicham El , Iyengar, Shruti K, Vemulapalli, Hema S , El Masry, Hicham , Baqal, Omar J , Kulthamrongsri, Narathorn

Journal of Clinical Medicine | August 26, 2024 | Volume: 13 | Issue: 17 | Pages: 5031

10.3390/jcm13175031 | PMID 39274244 Get It

Despite advances in ablative therapies, outcomes remain less favorable for persistent atrial fibrillation often due to presence of non-pulmonary vein triggers and abnormal atrial substrates. This review highlights advances in ablation technologies and notable scientific literature on clinical outcomes associated with pursuing adjunctive ablation targets and substrate modification during persistent atrial fibrillation ablation, while also highlighting notable future directions.
Predictors for Development of Chronic Rhinosinusitis in Transplant Recipients
Candelo, Estephanía , Bohorquez‐Caballero, Anyull D. , Avila‐Castano, Karol , Mercado, Lydia A., Donaldson, Angela M. , Donaldson, Angela, Gomez, Estephania Candelo

American Journal of Rhinology & Allergy | August 26, 2024 | Volume: 38 | Issue: 6 | Pages: 373-383

10.1177/19458924241272990 | PMID 39183515 Get It

Objectives Studies suggest that transplant patients are at a higher risk of developing chronic rhinosinusitis (CRS). However, there is a dearth of studies describing the factors that may be linked to the development of CRS in this population. Our objective is to identify the risk factors associated with the development of CRS in transplant recipients. Study design Retrospective cohort. Setting Tertiary care center. Methods This cohort included 3347 transplant recipients seen between 2017 and 2022. Of these, 2128 patients met the inclusion criteria and were grouped according to whether they were diagnosed with CRS during the post-transplant period. The analysis included both univariate and multivariate analysis to ascertain the odds ratio (OR) and predictive factors. Results Of the 2128 patients, 649/2128 (30.4%) had CRS. CRS patients had an increased prevalence of previous endoscopic sinus surgery, allergic rhinitis, and recurrent acute rhinosinusitis in the pre-transplant period compared to the non-CRS group. According to the multivariate analysis, patients with primary immunodeficiency and additional transplant were 1.9 and 3.1 times more likely to develop CRS during the posttransplant period (95% CI: 1.3–2.6, p < .0001), (95% CI: 1.3 −7.3, p = .01), respectively. Sirolimus use was also associated with the development of CRS (OR = 1.4, 95% CI: 1.1–1.9, p = .01). Conclusion This study is the largest cohort aimed at determining the predictive factors associated with the development of CRS. Patients with pretransplant rhinologic conditions, hematologic deficiencies, and the utilization of specific immunosuppressants were found to have a higher likelihood of developing CRS following transplantation.
Impact of NSD1 Alternative Transcripts in Actin Filament Formation and Cellular Division Pathways in Fibroblasts
Conteduca, Giuseppina , Baldo, Chiara , Arado, Alessia , Wagner, Ryan T. , Robertson, Keith D. , Dequiedt, Samuel , Fitzsimmons, Lane, Malacarne, Michela , Filaci, Gilberto , Coviello, Domenico , Baldo, Chiara , Wagner, Ryan T , Robertson, Keith D , Dequiedt, Franck , Filaci, Gilberto , Coviello, Domenico A , Cangelosi, Davide , Testa, Barbara

Genes | August 26, 2024 | Volume: 15 | Issue: 9 | Pages: 1117

10.3390/genes15091117 | PMID 39336709 Get It

Germline variants in the NSD1 gene are responsible for Sotos syndrome, while somatic variants promote neoplastic cell transformation. Our previous studies revealed three alternative RNA isoforms of NSD1 present in fibroblast cell lines (FBs): the canonical full transcript and 2 alternative transcripts, termed AT2 (NSD1 Δ5Δ7) and AT3 (NSD1 Δ19–23 at the 5′ end). The precise molecular pathways affected by each specific isoform of NSD1 are uncharacterized to date. To elucidate the role of these isoforms, their expression was suppressed by siRNA knockdown in FBs and protein expression and transcriptome data was explored. We demonstrate that one gene target of NSD1 isoform AT2 is ARP3 actin-related protein 3 homolog B (ACTR3B). We show that loss of both canonical NSD1 and AT2 isoforms impaired the ability of fibroblasts to regulate the actin cytoskeleton, and we observed that this caused selective loss of stress fibers. Our findings provide novel insights into NSD1 function by distinguishing isoform function and demonstrating an essential role of NSD1 in regulating the actin cytoskeleton and stress fiber formation in fibroblasts.
Vascularized bone grafts in spinal reconstruction: An updated comprehensive review
Abdulwadood, Isra , Gomez, Diego A. , Martinez, Casey , Bohl, Michael A. , Ropper, Alexander E., Winocour, Sebastian, Reece, Edward M., Gomez, Diego A

Orthoplastic Surgery | August 25, 2024 | Volume: 17 | Issue: C | Pages: 7-14

10.1016/j.orthop.2024.08.003 Get It

ABSTRACT In the past two decades, plastic surgeons have advanced to the forefront of spinal surgery, joining orthopedic and neurosurgeons in the multidisciplinary field of spino-plastics. As the global disease burden grows with an increased incidence of spinal pathologies, vascularized bone grafts (VBGs) define the current frontier of spino-plastic surgery. Vascularized bone grafting involves lifting segments of bone with the muscular attachments but without the inclusion of a named vessel. When compared to traditional nonvascular bone grafts and allografts, VBGs have come forward as a favored technique for complex spinal reconstruction due to the unique opportunity to capitalize on the relationship between the tendons and Sharpey's fibers which maintain blood flow to both the bone and muscular segments. This technique ensures robust autologous tissue rearrangement and also takes advantage of the osteoinductive properties of the bone segments, promoting adequate structural support and the perfusion necessary for efficient direct healing and fusion in intricate spine reconstructions. Another one of the many favorable qualities of VBGs is the diversity of sources available to surgeons. The review explores the role of VBGs in enhancing spinal fusion rates and minimizing morbidity compared to traditional approaches. Additionally, a detailed examination of six common VBG sources-the iliac crest, ribs, medial scapula, occiput, spinous processes, and clavicle is included, highlighting each graft's specific techniques and emphasizing the range of options available to spino-plastic surgeons. Highlights Vascularized Bone Grafts (VBGs) have emerged as a favored technique in complex spinal reconstruction.The field of spino-plastic surgery highlights the collaboration between plastic, orthopedic, and neurosurgery.The article outlines the reconstructive ladder for bony defects, with VBGs being a critical addition.Advantages of VBGs include enhanced fusion rates, lower risk of infection, and reduced operative time.Preserving the vascular supply during graft harvest is crucial.Preoperative planning is essential as VBG selection is made on a case-by-case basis.
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance)
Brown, Justin C. , Shi, Qian , Couture, Félix , Kuebler, Philip , Kumar, Pankaj , Tan, Benjamin , Krishnamurthi, Smitha , Chang, Victor T. , Goldberg, Richard M. , Shields, Anthony F. , Meyerhardt, Jeffrey A. , Brown, Justin C. , Kuebler, J. Philip , Shi, Qian , Chang, Victor T-S , Shields, Anthony F , Brown, Justin C , Meyerhardt, Jeffrey A , Ma, Chao , Goldberg, Richard M. , O’Reilly, Eileen M. , Brown, Justin C.

JNCI: Journal of the National Cancer Institute | August 24, 2024 | Volume: 116 | Issue: 12 | Pages: 2032-2039

10.1093/jnci/djae203 | PMID 39180477 Get It

Abstract Background Inflammation and insufficient physical inactivity contribute to individual-level risk of disease recurrence and death in stage III colon cancer. The extent to which increased inflammatory risk can be offset by sufficient physical activity remains unknown. Methods This cohort study was nested within the Cancer and Leukemia Group B (now part of the Alliance for Clinical Trials in Oncology) and Southwest Oncology Group randomized trial. Inflammatory burden was quantified by high-sensitivity C-reactive protein, interleukin-6, and soluble tumor necrosis factor-α receptor 2 after recovery from tumor resection. Physical activity was measured during and after postoperative chemotherapy. The primary endpoint was disease-free survival. Results The 3-year disease-free survival rate was 88.4% among patients with low inflammation and sufficient physical activity (referent group for all comparisons), 84.9% with low inflammation and insufficient physical activity (absolute risk difference = −3.5 percentage points, 95% confidence interval [CI] = −11.3 to 4.3; P = .38), 78.0% with intermediate inflammation and insufficient physical activity (absolute risk difference = −10.4 percentage points, 95% CI = −17.4 to −3.3; P = .007), and 79.7% with high inflammation and insufficient physical activity (absolute risk difference = −8.7 percentage points, 95% CI = −15.7 to −1.6; P = .022). In contrast, the 3-year disease-free survival rate was 87.3% among patients with intermediate inflammation and sufficient physical activity (absolute risk difference = −1.1 percentage points, 95% CI = −7.5 to 5.3; P = .74) and 84.4% with high inflammation and sufficient physical activity (absolute risk difference = −4.0 percentage points, 95% CI = −12.3 to 4.3; P = .34). Conclusion In this observational study of stage III colon cancer patients, physical activity was associated with improved disease-free survival despite high inflammation. Patients with intermediate or high inflammation who were physically active had disease-free survival rates that were not statistically significantly different from those with low inflammation.
The impact of cadaveric donor transplant on the development of chronic rhinosinusitis and recalcitrant disease
Candelo, Estephanía , Bohorquez‐Caballero, Anyull D. , Avila‐Castano, Karol , Wadei, Hani M. , Donaldson, Angela M. , Wadei, Hani, Gomez, Estephania Candelo , Caballero, Anyull D. B. , Wadei, Hani M

International Forum of Allergy & Rhinology | August 24, 2024 | Volume: 14 | Issue: 12 | Pages: 1953-1956

10.1002/alr.23429 | PMID 39180300 Get It

Key points The study found a higher incidence of chronic rhinosinusitis (CRS) and recalcitrant CRS in cadaveric organ transplant recipients compared to those receiving living donor transplants. Recipients of cadaveric transplants were 1.32 times more likely to develop CRS and 1.68 times more likely to develop medically recalcitrant CRS. Living kidney transplants significantly reduced the risk of developing CRS (OR = 0.12) and recalcitrant CRS (OR = 0.11), highlighting a potentially protective effect against these conditions. In contrast, cadaveric liver transplants were associated with an increased risk of CRS and medically recalcitrant CRS. Kaplan–Meier survival analysis indicated a significant difference in time to CRS onset between cadaveric and living donor transplants. Median time to CRS onset was longer for living donor recipients (21.1 months) compared to cadaveric recipients (15.6 months). This study underscores the need for transplant teams and otolaryngologist to consider donor type during transplant follow‐up due to differing risks of CRS development.
Development and implementation of a roadmap for improving quality of care in prearthritic hip disease: A journey over 20 years
Clohisy, John C. , Nepple, Jeffrey J. , Zaltz, Ira , Millis, Michael B. , Sierra, Rafael J. , Kim, Young Jo , Sucato, Daniel J. , Sink, Ernest L. , Group, ANCHOR, Beaulé, Paul E , Millis, Michael B , Sierra, Rafael J , Beaulé, Paul E. , Group, ANCHOR

Journal of Orthopaedic Research | August 24, 2024 | Volume: 42 | Issue: 11 | Pages: 2362-2372

10.1002/jor.25953 | PMID 39180284 Get It

Abstract The understanding and treatment of prearthritic hip disease has evolved remarkably over the past 20 years. The principal investigator and the multicenter Academic Network of Conservational Hip Outcomes Research (ANCHOR) group have had a key role in improving the quality of care for these patients suffering from the three most common prearthritic conditions: femoroacetabular impingement, developmental dysplasia of the hip, and residual Legg‐Calve‐Perthes Disease. We aim to demonstrate that based on the six quality of care dimensions as defined by Donabedian, our 20‐year academic journey has markedly improved the quality of care for young patients with prearthritic hip disease.